Effects of multi-ion beams in combination with sotorasib on KRAS G12C mutant pancreatic cancer cells

被引：0
|
作者：
Sai, Sei [1 ]
Kang, Yumei [2 ,3 ]
Suzuki, Masao [1 ]
Yamada, Shigeru [2 ]
Koto, Masashi [1 ,2 ]
机构：
[1] QST, Dept Charg Part Ther Res, Chiba, Japan
[2] QST Hosp, Chiba, Japan
[3] Taipei Vet Gen Hosp, Dept Oncol, Taipei, Taiwan
来源：
CANCER SCIENCE | 2023年 / 114卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E-3026
引用
收藏
页码：1592 / 1592
页数：1
相关论文
共 50 条
  • [11] Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer
    Kavgaci, Gozde
    Dizdar, Omer
    Yalcin, Suayib
    ANTI-CANCER DRUGS, 2024, 35 (05) : 459 - 461
  • [12] Sotorasib in KRAS p.G12C-Mutated Advanced Pancreatic Cancer
    Strickler, J. H.
    Satake, H.
    George, T. J.
    Yaeger, R.
    Hollebecque, A.
    Garrido-Laguna, I.
    Schuler, M.
    Burns, T. F.
    Coveler, A. L.
    Falchook, G. S.
    Vincent, M.
    Sunakawa, Y.
    Dahan, L.
    Bajor, D.
    Rha, S. -Y.
    Lemech, C.
    Juric, D.
    Rehn, M.
    Ngarmchamnanrith, G.
    Jafarinasabian, P.
    Tran, Q.
    Hong, D. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (01): : 33 - 43
  • [13] A Case Series of Patients With Kras KRAS G12C Mutation Treated With Sotorasib - Croatian Experience
    Seiwerth, F.
    Bitar, L.
    Franolic, I. Lukic
    Sajnic, A.
    Jakopovic, M.
    Samarzija, M.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S426 - S426
  • [14] Sotorasib: a treatment for non-small cell lung cancer with the KRAS G12C mutation
    Zheng, Xinting
    Luo, Jiamin
    Liu, Wei
    Ashby, Charles R., Jr.
    Chen, Zhe-Sheng
    Lin, Lizhu
    DRUGS OF TODAY, 2022, 58 (04) : 175 - 185
  • [15] Sotorasib for KRAS p.G12C-mutated advanced pancreatic cancer
    Baker, Holly
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (03): : 213 - 213
  • [16] EMT is a cause of both intrinsic and acquired resistance to KRAS G12C inhibitor in KRAS G12C mutant NSCLC
    Adachi, Yuta
    Ito, Kentaro
    Kimura, Ryo
    Yamaguchi, Rui
    Ebi, Hiromichi
    ANNALS OF ONCOLOGY, 2021, 32 : S307 - S307
  • [17] Synergistic antitumor activity of nab-sirolimus in combination with KRAS inhibitors (KRASis) sotorasib and adagrasib in KRAS G12C NSCLC and bladder cancer xenografts
    Hou, Shihe
    Kwon, Andrew
    Nieva, Jorge
    Desai, Neil
    CANCER RESEARCH, 2023, 83 (07)
  • [18] Establishment of KRAS G12C mutant brain metastasis models for preclinical evaluation of KRAS G12C targeted anticancer therapy
    Chen, Qikuan
    Wang, Guilan
    Yin, Yingfei
    CANCER RESEARCH, 2024, 84 (06)
  • [19] AXL signal mediates adaptive resistance to KRAS G12C inhibitors in KRAS G12C-mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Fukui, Sarina
    Sawada, Ryo
    Tachibana, Yusuke
    Matsui, Yohei
    Nakamura, Ryota
    Ishida, Masaki
    Kawachi, Hayato
    Kunimasa, Kei
    Sasaki, Takaaki
    Nishida, Makoto
    Furuya, Naoki
    Watanabe, Satoshi
    Shiotsu, Shinsuke
    Nishioka, Naoya
    Horinaka, Mano
    Sakai, Toshiyuki
    Uehara, Hisanori
    Yano, Seiji
    Son, Bo-Kyung
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER LETTERS, 2024, 587
  • [20] A phase 1/2 study of VS-6766 (RAF/MEK clamp) in combination with sotorasib (G12C inhibitor) in patients with KRAS G12C mutant non-small cell lung cancer (NSCLC) (RAMP 203).
    Govindan, Ramaswamy
    Awad, Mark M.
    Gadgeel, Shirish M.
    Pachter, Jonathan A.
    Patrick, Gloria
    Denis, Louis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345